CLDI Stock Analysis: Buy, Sell, or Hold?
CLDI - Calidi Biotherapeutics, Inc.
$1.70
0.02 (1.19%)
▲
5d:
+1452.51%
30d:
+1040.94%
90d:
+685.58%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 14, 2026
9d
Get Alerted When CLDI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CLDI is 962.5% above its trading range ($0.16). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CLDI is 962.5% above its trading range ($0.16). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CLDI is currently trading at $1.70, which is considered oversold relative to its 30-day fair value range of $0.11 to $0.16.
Technical Outlook: Technically, CLDI is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $1.93.
Market Sentiment: CLDI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $120.00 (+7043.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLDI is in a strong uptrend. Immediate support is located at $0.09, while resistance sits at $1.93.
Market Sentiment: CLDI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $120.00 (+7043.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.11 -
$0.16
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 7043.1% below Wall St target ($120.00)
- WARNING: Recommendation downgraded due to 962.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.11 -
$0.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.09
Resistance Level
$1.93
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.30
Wall Street Target
$120.00
(+7043.1%)
Share & Embed Analysis
Last updated: August 04, 2026 9:55 AM ET
Data refreshes hourly during market hours. Next update: 10:55 AM
Data refreshes hourly during market hours. Next update: 10:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 51 HOLD |
